SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Cents and Sensibility - Kimberly and Friends' Consortium -- Ignore unavailable to you. Want to Upgrade?


To: star56 who wrote (21547)11/1/1999 11:35:00 AM
From: Kimberly Lee  Read Replies (1) | Respond to of 108040
 
bought GUMM 15 3/4. huge news - reducing duration of cold by 85%. 10:45 ET GumTech International (GUMM) 15 11/16 +1 5/16 (+9%): Company's Gel Tech
joint-venture unit announces that the American Journal of Infection Control (AJIC) will publish the
results of a scientific study on Zicam. According to the initial study, Zicam reduced the duration of the
common cold by an average of 85% and significantly reduced the severity of colds including nasal
congestion, sneezing, coughing, and sore throat. Volume 316K; intraday range 15 3/16 to 16.

Technically, it's breaking out on large volume, very bullish